Insider Trading disclosures for Tekla World Healthcare Fund

The latest disclosure was made by C. William Maher in Tekla World Healthcare Fund where a trade of 1,000 Common Stock done at an average price of $13.0 was reported to US exchanges on Aug. 14, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
C. William Maher Director Purchase of securities on an exchange or from another person at price $ 13.03 per share. 14 Aug 2024 1,000 1,000 (0%) 0% 13.0 13,030 Common Stock
Rose DiMartino Director Purchase of securities on an exchange or from another person at price $ 13.31 per share. 16 Jul 2024 1,000 1,000 (0%) 0% 13.3 13,310 Common Stock
Kathleen L. Goetz Director Purchase of securities on an exchange or from another person at price $ 12.53 per share. 09 Apr 2024 200 1,017 (0%) 0% 12.5 2,506 Common Stock
Reit Todd Director Purchase of securities on an exchange or from another person at price $ 11.94 per share. 02 Jan 2024 1,000 1,000 (0%) 0% 11.9 11,936 Common Stock
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 14.57 per share. 23 Mar 2022 103 817 (0%) 0% 14.6 1,501 Shares of Beneficial Interest
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 14.60 per share. 26 Jan 2022 714 714 (0%) 0% 14.6 10,426 Shares of Beneficial Interest
William S. Reardon Director 06 Apr 2021 1,460 0 - - Subscription rights
Lucinda H. Stebbins Director 06 Apr 2021 750 0 - - Subscription Rights
Jeffrey Allen Bailey Director 06 Apr 2021 735 0 - - Subscription Rights
Jeffrey Allen Bailey Director 06 Apr 2021 245 980 (0%) 0% 14.3 3,494 Shares of Beneficial Interest
William S. Reardon Director 06 Apr 2021 486 1,946 (0%) 0% 14.3 6,931 Shares of Beneficial Interest
Thomas M. Kent Director 06 Apr 2021 1,800 0 - - Subscription Rights
Thomas M. Kent Director 06 Apr 2021 600 2,400 (0%) 0% 14.3 8,557 Shares of Beneficial Interest
Daniel R. Omstead Director, President 06 Apr 2021 24,326 0 - - Subscription Rights
Daniel R. Omstead Director, President 06 Apr 2021 6,442 30,768 (0%) 0% 14.3 91,876 Shares of Beneficial Interest
Lucinda H. Stebbins Director 06 Apr 2021 250 1,000 (0%) 0% 14.3 3,566 Shares of Beneficial Interest
William S. Reardon Director Purchase of securities on an exchange or from another person at price $ 17.14 per share. 25 Feb 2021 1,460 1,460 (0%) 0% 17.1 25,024 Shares of Beneficial Interest
Lucinda H. Stebbins Director Purchase of securities on an exchange or from another person at price $ 16.80 per share. 19 Feb 2021 750 750 (0%) 0% 16.8 12,600 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 10.77 per share. 17 Mar 2020 9,926 24,326 (0%) 0% 10.8 106,932 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 11.11 per share. 26 Dec 2018 9,400 14,400 (0%) 0% 11.1 104,411 Shares of Beneficial Interest
Thomas M. Kent None Purchase of securities on an exchange or from another person at price $ 14.52 per share. 25 Jan 2018 1,800 1,800 (0%) 0% 14.5 26,128 Shares of Beneficial Interest
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures